Listed by the USPTO as KASAYAN, KATRIEL BARCELLANO
Tech Center 1700 • Art Units: 1600 1611 1634 1643 1773
This examiner grants 25% of resolved cases
Katriel Barcellano Kasayan has resolved 4 cases in Art Unit 1600, resulting in a 25.0% allowance rate. This resolution took a median of 1207 days to reach allowance within Tech Center 1700. The interview lift pct is currently 0.0%, suggesting that interviews have not yet impacted the success rate for these early cases.
Companies such as University of Florida Research Foundation Inc., Board of Regents of the University of Texas System, and Massachusetts Institute of Technology are listed among the top entities. Firms like ALSTON & BIRD LLP, TROUTMAN PEPPER LOCKE LLP, and BIOTECH BEACH LAW PC have handled prosecution in this profile.
With only 4 resolved cases, the 25.0% allowance rate and 1207-day median pendency offer a preliminary view of the prosecution environment. The 0.0% interview lift pct indicates that applicants have yet to find a statistical advantage through verbal negotiation. Practitioners should prepare for a potentially lengthy process given the current 1207-day timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18331891 | DIRECT CONVERSION OF HUMAN MESENCHYMAL STEM CELLS TO HUMAN CARDIOMYOCYTES | Final Rejection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 17802686 | COMPOSITIONS, METHODS, KITS, AND SYSTEMS RELATING TO CHARGE-NEUTRAL MICROGELS FOR 3D CELL CULTURE AND PRINTING | Non-Final OA | University of Florida Research Foundation, Inc. |
| 17308462 | COMPOSITIONS AND METHODS RELATING TO REVERSIBLY COMPRESSIBLE TISSUE-HYDROGEL HYBRIDS | Final Rejection | Massachusetts Institute of Technology |
| 18838347 | NEURAL PROGENITOR CELL COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | The General Hospital Corporation |
| 18689676 | METHOD FOR IMPROVING GENOME EDITING | Final Rejection | The Regents of the University of California |
| 18750595 | METHOD OF CULTURING THREE-DIMENSIONAL CELLULAR TISSUES | Non-Final OA | TOPPAN HOLDINGS INC. |
| 18171415 | METHOD FOR PRODUCING THREE-DIMENSIONAL CELL STRUCTURE, AND THREE-DIMENSIONAL CELL STRUCTURE | Non-Final OA | TOPPAN Inc. |
| 17285908 | COMPOSITIONS FOR AND METHODS OF PRODUCING TUMOR ORGANOIDS | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18014850 | TDP-43 BIOSENSOR CELL LINES | Final Rejection | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18708777 | MATERIALS AND METHODS FOR SLC6A1 GENE THERAPY | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18705554 | METHOD OF MOUNTING A BIOLOGICAL SAMPLE ON A SURFACE | Final Rejection | RESOLVE BIOSCIENCES GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy25.0% of resolved applications examined by Katriel Barcellano Kasayan were allowed (4 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Katriel Barcellano Kasayan took 1,207 days on average from filing to allowance.
Katriel Barcellano Kasayan examines applications in Art Unit 1600 in Tech Center 1700 (Chemistry & Materials).
